Selected References:
- Altshuler LL, et al. 1996. Pharmacologic Management of Psychiatric Illness during Pregnancy: Dilemmas and Guidelines. Am J Psychiatry, 153(5):592-606.
- Ban L, et al. 2012. Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study. PLoS ONE, 7(8):e43462.
- Bennet PN, The WHO Working Group. 1988. Drugs and Human Lactation. Elsevier, Amsterdam, New York, Oxford, pp. 289-290.
- Committee on Drugs, American Academy of Pediatrics. 2001. The transfer of drugs and other chemicals into human breast milk. Pediatrics, 108:776-89.
- Deligiannidis K, et al. 2014. A Review of Pharmacokinetic Changes and Clinical Recommendations for Therapeutic Drug Monitoring. J Clin Psychopharmacology, 34(2):244-255.
- Desaunay P, et al. 2022. Neonatal hypotonia following in utero exposure to antidepressant drugs. J Pediatr, 245:222–226.e2.
- Ericson A, et al. 1999. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol, 55:503-508.
- Hemels MEH, et al. 2005. Antidepressant Use During Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis. Ann Pharmacother, 39(5):803-809.
- Horst PGJ, et al. 2011. Clomipramine concentration and withdrawal symptoms in 10 neonates. Br J Clin Pharmacol, 73(2):295-302.
- Huybrechts KF, et al. 2015. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA, 313(21):2142-2151.
- Larsen ER, et al. 2015. Use of psychotropic drugs during pregnancy and breastfeeding. Acta Psychiatr Scand, 132:1-28.
- McElhatton PR, et al. 1996. The Outcome of Pregnancy in 689 Women Exposed to Therapeutic Doses of Antidepressants. A Collaborative Study of The European Network of Teratology Information Services (ENTIS)
- Misri S, et al. 1991. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med, 21(2):157-171.
- Mitchell JE, Popkin MK. 1983. Antidepressant drug therapy and sexual dysfunction in men: a review. J Clin Psychopharm, 3:76-79.
- Nulman I, et al. 1997. Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs. The New England Journal of Medicine, 336(4):258-262.
- Nulman I, et al. 2002. Child Development Following Exposure to Tricyclic Antidepressant or Fluoxetine throughout Fetal Life: A Prospective, Controlled Study. Am J Psychiatry, 159(11):1889-1895.
- Osborne LM, et al. 2014. Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges. Arch Womens Ment Health, 17:239-246.
- Pearson KH, et al. 2007. Birth Outcomes Following Prenatal Exposure to Antidepressants. J Clin Psychiatry, 68(8):1284-1289.
- Shah AA, et al. 2015. Are Psychotropic Drugs Safe to Use During Lactation? Psychiatric Annals, 45(2):77-82.
- Shatan C, et al. 1966. Withdrawal Symptoms after Abrupt Termination of Imipramine. Canadian Psychiatric Association Journal, 11:150-158.
- Uguz F, et al. 2014. Low-dose imipramine for treatment of panic disorder during pregnancy: a retrospective chart review. J Clin Psychopharmacol, 34(4):513-515.